Clinical trial · Observational
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944CI-TRIAL-00074842recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Multicentre, retrospective and prospective observational study aimed to set-up a clinical Italian registry in order to collect information on carcinoma of the Head and Neck.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Carcinoma | Head and Neck Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| observational-retrospective and prospective | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- types of diagnostic and treatment patterns
- timeFrame
- From the enrollment to the end of the study (5 years)
- description
- To document types of diagnostic and treatment patterns by all stages of disease and frequency, and proportion with which they are used in the different stages of Head and Neck cancer.
Secondary outcomes (10)
- measure
- proportion of patients in the different stage of disease
- timeFrame
- From the enrollment to the end of the study (5 years)
- description
- To estimate the proportion of patients in the different stage of disease (TNM staging system 8\^ edition) in the overall Head and Neck cancer patient population.
- measure
- treatment outcomes
- timeFrame
- From the enrollment to the end of the study (5 years)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adult patients (age ≥ 18 years old) diagnosed with carcinoma of the Head and Neck. The diagnosis should be done or verified by the expert site entering the information about the patient in the registry. Patients diagnosed with sarcomas and lymphomas are excluded. 2. Patients entering the HCP at any clinical phase of the disease (diagnosis, treatment of primary cancer, treatment of recurrence, treatment of M+ etc.). The HCP will collect information on the entire disease regardless of when it started to manage the patient. The HCP can choose, based on its resources, for how many patients will be able to collect the data. 3. New patients managed by the HCP from 2021 onwards + patients managed by the HCP, in active follow-up at the hospital Exclusion Criteria: 1\. Patients whose medical records are unavailable for review
References
Publications (0)
Data not yet available
No reference posted for this study.